Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Lishui Zhongyi Pharmaceutical is a pharmaceutical manufacturing company based in Lishui, China, specializing in the production of chemical finished dosages. Since its acquisition by Zhejiang Jingxin Pharmaceutical in 2015, the company has served as a core production hub for various therapeutic categories, including cardiovascular, anti-infective, and digestive health. Its commercial portfolio features widely used generic medications such as Simvastatin tablets and Clarithromycin sustained-release tablets. Operating from GMP-certified facilities, the company focuses on high-quality drug production to support its parent group's expansion in the Chinese domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Lishui Zhongyi Pharmaceutical.